Profile data is unavailable for this security.
About the company
ZhuZhou QianJin Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production, wholesaling and retailing of drugs. The Company's main products include tablets, granules, pills, hard capsules, syrups, herbs, vinum and gels, among others. The company is also involved in the businesses of cultural entertainment, logistics and distribution, as well as the provision of hygienic products.
- Revenue in CNY (TTM)3.81bn
- Net income in CNY321.42m
- Incorporated1993
- Employees5.34k
- LocationZhuZhou QianJin Pharmaceutical Co LtdNo.801 Zhuzhou Avenue, Tianyuan DistrictZHUZHOU 412000ChinaCHN
- Phone+86 73 122492897
- Fax+86 73 122496088
- Websitehttp://www.qjyy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Yabao Pharmaceutical Group Co Ltd | 2.82bn | 211.33m | 4.26bn | 4.14k | 20.51 | 1.48 | -- | 1.51 | 0.2886 | 0.2886 | 3.78 | 3.99 | 0.7255 | 3.17 | 6.31 | 680,979.10 | 4.85 | 2.82 | 6.22 | 3.97 | 55.14 | 59.20 | 6.68 | 4.19 | 1.64 | 75.03 | 0.0779 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
Pulike Biological Engineering Inc | 1.12bn | 130.97m | 4.29bn | 1.68k | 33.13 | 1.62 | -- | 3.83 | 0.3743 | 0.3743 | 3.18 | 7.65 | 0.3485 | 2.33 | 2.66 | 667,816.40 | 4.07 | 7.64 | 4.77 | 8.96 | 60.15 | 62.57 | 11.68 | 17.85 | 2.26 | -- | 0.0127 | 52.48 | 1.84 | 15.55 | 3.99 | 5.17 | 41.58 | 18.47 |
Shanghai Hile Bio-Technology Co Ltd | 220.43m | 33.32m | 4.32bn | 295.00 | 137.79 | 3.37 | -- | 19.61 | 0.0477 | 0.0477 | 0.3333 | 1.95 | 0.1358 | 1.12 | 2.36 | 747,217.40 | 1.33 | 1.73 | 1.67 | 2.47 | 43.60 | 50.44 | 9.83 | 10.37 | 1.13 | -- | 0.174 | 23.89 | -19.76 | -1.11 | -48.30 | 24.17 | -41.32 | 23.47 |
Zhejiang Shouxiangu Pharmaceuticl Co Ltd | 765.44m | 265.12m | 4.41bn | 1.14k | 16.45 | 2.03 | -- | 5.77 | 1.35 | 1.35 | 3.89 | 10.94 | 0.2496 | 0.7366 | 8.34 | 669,678.30 | 8.65 | 10.04 | 10.50 | 11.63 | 81.12 | 83.66 | 34.64 | 28.29 | 3.25 | -- | 0.2226 | 47.86 | -5.39 | 8.93 | -8.39 | 18.78 | 12.23 | 17.13 |
ZhuZhou QianJin Pharmaceutical Co., Ltd | 3.81bn | 321.42m | 4.53bn | 5.34k | 14.22 | 1.89 | -- | 1.19 | 0.7513 | 0.7513 | 8.87 | 5.64 | 0.8606 | 3.70 | 9.48 | 714,144.30 | 9.03 | 8.99 | 16.81 | 16.21 | 45.17 | 44.59 | 10.49 | 10.03 | 2.01 | -- | 0.1552 | 68.27 | -5.66 | 2.68 | 5.53 | 4.64 | -1.06 | -2.64 |
Jinyao Pharmaceutical Co Ltd | 3.56bn | 135.67m | 4.54bn | 2.68k | 33.47 | 1.51 | -- | 1.28 | 0.124 | 0.124 | 3.26 | 2.75 | 0.5643 | 2.27 | 7.69 | 1,329,556.00 | 2.93 | 1.91 | 5.06 | 3.40 | 42.62 | 46.33 | 5.19 | 3.31 | 0.8002 | 16.12 | 0.2205 | 44.40 | 2.55 | 9.28 | 230.60 | -4.22 | -9.58 | 9.21 |
Jiangsu Jibeier Pharmaceutical Co Ltd | 875.78m | 244.83m | 4.65bn | 1.45k | 17.88 | 2.11 | -- | 5.31 | 1.31 | 1.31 | 4.67 | 11.04 | 0.3872 | 3.32 | 3.55 | 606,078.30 | 10.81 | 9.77 | 11.94 | 10.66 | 87.91 | 88.44 | 27.92 | 23.29 | 6.04 | -- | 0.0061 | 30.68 | 31.49 | 12.16 | 41.65 | 17.79 | 112.78 | -- |
Data as of Oct 11 2024. Currency figures normalised to ZhuZhou QianJin Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Huatai-PineBridge Fund Management Co., Ltd.as of 31 Mar 2023 | 12.64m | 3.02% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 6.29m | 1.50% |
Pacific Asset Management Co., Ltd.as of 31 Mar 2023 | 5.15m | 1.23% |
Zhong Ou Asset Management Co., Ltdas of 31 Mar 2023 | 4.13m | 0.99% |
China Fund Management Co., Ltd.as of 31 Mar 2023 | 4.00m | 0.96% |
China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 3.38m | 0.81% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 3.30m | 0.79% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 1.76m | 0.42% |
Western Leadbank Fund Management Co., Ltdas of 31 Dec 2023 | 1.55m | 0.37% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.41m | 0.34% |
More ▼
Data from 31 Dec 2023 - 31 Jul 2024Source: FactSet Research Systems Inc.